TH114622A - Chlorella sorokiniana extract - Google Patents
Chlorella sorokiniana extractInfo
- Publication number
- TH114622A TH114622A TH801004984A TH0801004984A TH114622A TH 114622 A TH114622 A TH 114622A TH 801004984 A TH801004984 A TH 801004984A TH 0801004984 A TH0801004984 A TH 0801004984A TH 114622 A TH114622 A TH 114622A
- Authority
- TH
- Thailand
- Prior art keywords
- acid
- extract
- palmitic
- linolenic
- stearic
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract 7
- 241000195654 Chlorella sorokiniana Species 0.000 title claims 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims abstract 12
- DTOSIQBPPRVQHS-PDBXOOCHSA-N α-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims abstract 10
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims abstract 8
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract 6
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims abstract 6
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract 6
- 235000021314 Palmitic acid Nutrition 0.000 claims abstract 6
- 239000002253 acid Substances 0.000 claims abstract 6
- 229960004488 Linolenic Acid Drugs 0.000 claims abstract 5
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract 5
- 235000021355 Stearic acid Nutrition 0.000 claims abstract 4
- 239000008117 stearic acid Substances 0.000 claims abstract 4
- 235000021360 Myristic acid Nutrition 0.000 claims abstract 3
- 239000005642 Oleic acid Substances 0.000 claims abstract 3
- 235000020778 linoleic acid Nutrition 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract 2
- SECPZKHBENQXJG-FPLPWBNLSA-N Palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 claims 2
- 235000021319 Palmitoleic acid Nutrition 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 239000005426 pharmaceutical component Substances 0.000 claims 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 abstract 2
- 206010012601 Diabetes mellitus Diseases 0.000 abstract 2
- 206010058108 Dyslipidaemia Diseases 0.000 abstract 2
- 206010061227 Lipid metabolism disease Diseases 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 2
- 235000020824 obesity Nutrition 0.000 abstract 2
- 235000021313 oleic acid Nutrition 0.000 abstract 2
Abstract
DC60 การประดิษฐ์นี้เกี่ยวข้องกับสารสกัดของ Chlorella sorokinana ซึ่งจะมีไมสริสทิค แอซิด, ปาลมิทิค แอซิด, ปาลมิทิค แอซิด, ปาลมิโทเลธิค แอซิด, โอเลอิค แอซิด, ลิโนเลอิค แอซิด, ลิโนเลนิค แอซิด, และ สเตียริค แอซิด นอกจากนี้การประดิษฐ์นี้ยังเกี่ยวข้องกับการใช้สารสกัดนี้เพื่อบำบัด โรคเบาหวาน, โรคอ้วน, และ ภาวะไขมันในเลือดผิดปกติ การประดิษฐ์นี้เกี่ยวข้องกับสารสกัดของ Chlorella sorokinana ซึ่งจะมีไมสริสทิค แอซิด, ปาลมิทิค แอคซิด, ปาลมิทิค แอซิด, ปาลมิโทเลธิค แอซิด, โอเลอิค แอซิด, ลิโนเลอิค แอซิด, ลิโนเลนิค แอซิด, และ สเตียริค แอซิด นอกจากนี้การประดิษฐ์นี้ยังเกี่ยวข้องกับการใช้สารสกัดนี้เพื่อการบำบัด โรคเบาหวาน, โรคอ้วน, และภาวะไขมันในเลือดผิดปกติ สิทธิบัตรยา DC60 This invention involves extracts of Chlorella sorokinana, which contain myristic acid, palmitic acid, palmitic acid, palmitolethic acid, Oleic acid, linoleic acid, linolenic acid, and stearic acid. In addition, this invention involved the use of this extract for the treatment of Diabetes, Obesity, and Dyslipidemia The invention involves extracts of Chlorella sorokinana, which contain myristic acid, palmitic acid, palmitic acid, palmitolethic acid, Oleic acid, linoleic acid, linolenic acid, and stearic acid. In addition, this invention involves the use of this extract for Treatment of diabetes, obesity and dyslipidemia, patent medicine
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH114622A true TH114622A (en) | 2012-06-29 |
| TH114622B TH114622B (en) | 2012-06-29 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2496892T3 (en) | Formulations for the treatment of upper respiratory tract disorders | |
| BR112015000150A2 (en) | controlled release abuse deterrent pharmaceutical compositions | |
| MX2012003555A (en) | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same. | |
| AR078247A1 (en) | PCSK9 VACCINE | |
| PH12015500407B1 (en) | Methods of treating hypertriglyceridemia | |
| CL2013003372A1 (en) | Compounds derived from spiro- [1,3] -oxacins and spiro- [1,4] -oxacepins, inhibitors of bace1 and / or bace2; pharmaceutical composition; procedure to prepare them; and its use in the treatment and / or prophylaxis of Alzheimer's disease and diabetes. | |
| DK2451445T3 (en) | PROCEDURE FOR DRYING BIBW2992, IT'S SALTS AND SOLID PHARMACEUTICAL FORMULATIONS INCLUDING THIS ACTIVE INGREDIENT | |
| WO2011026125A3 (en) | Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen | |
| BRPI1009252A2 (en) | compound, prodrug, pharmaceutical composition, methods for preventing or treating central nervous system disease, and alzheimer's disease, and use of the compound or a prodrug thereof | |
| BRPI0807285A2 (en) | "COMPOSITION, METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION, UNIT FORM OF DOSAGE, METHOD FOR ADMINISTRATING A BIOLOGICAL ACTIVE AGENT NEEDING THE AGENT, METHOD FOR INCREASING BIODISPONABILITY FOR PREPARING AN AGENT OF COMPOSITION" | |
| EP4218823A3 (en) | Novel polymeric hgh prodrugs | |
| MY149112A (en) | Extracts from chlorella sorokiniana | |
| WO2013148686A3 (en) | Stable igg4 binding agent formulations | |
| DK1820506T3 (en) | Extended release dipyridamole formulations and process for their preparation | |
| EP4233896A3 (en) | Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells | |
| WO2009102443A3 (en) | Octanoic acid formulations and methods of treatment using the same | |
| PH12015502556A1 (en) | Modified release formulation | |
| CL2014003325A1 (en) | Compounds derived from difluoro-hexahydro-cyclopentaoxacinyls and difluoro-hexahydro-benzooxacinyls, bace 1 inhibitors; pharmaceutical composition; and its use in the treatment of diseases with elevated levels of beta-amyloid, such as Alzheimer's disease | |
| WO2011072069A3 (en) | Gastric retentive pharmaceutical compositions for extended release of polypeptides | |
| JP2017537912A5 (en) | ||
| MX2012000954A (en) | Pharmaceutical compositions. | |
| CL2014002248A1 (en) | Pharmaceutical composition comprising snail drool helix aspersa müller (5% to 50%), chamomile extract (5% to 10%) and honey (5% to 10%); preparation procedure; use of the composition because it serves to prepare a medicament or device useful for preventing or treating lesions derived from psoriasis. | |
| WO2011129579A3 (en) | Oral pharmaceutical composition comprising fenofibric acid and an alkalifying agent | |
| MX2018010727A (en) | Crystalline(2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl] -4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-m ethylpentanoic acid and uses thereof. | |
| TH114622A (en) | Chlorella sorokiniana extract |